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Purpose:  To assess  whether  contrast-enhanced  T1-weighted  MR Cholangiography  may  provide  additional
information  in  the  evaluation  of  biliary  complications  in orthotopic  liver  transplant  recipients.
Material  and  methods:  Eighty  liver  transplant  patients  with  suspicion  of  biliary  adverse  events  underwent
MR  imaging  at  1.5  T scanner.  After  acquisition  of  axial  T1-/T2-weighted  images  and  conventional  T2-
weighted  MR  Cholangiography  (image  set  1),  3D  gradient-echo  T1-weighted  fat-suppressed  LAVA  (Liver
Acquisition  with  Volume  Acceleration)  sequences  were  obtained  about 30 min  after  intravenous  infusion
of mangafodipir  trisodium  (Mn-DPDP,Teslascan®) (image  set  2). The  diagnostic  value  of  mangafodipir
trisodium-enhanced  MR Cholangiography  in  the  detection  of  biliary  complications  was  tested  by  separate
analysis  results  of image  set  1  alone  and  image  set  1  and  2  together.  MRI results  were  correlated  with  direct
cholangiography  in 46 patients,  surgery  in  14  and/or  clinical-radiological  follow-up  in the  remaining  20
cases.
Results:  The  level  of  conﬁdence  in  the  assessment  of  biliary  adverse  events  was  signiﬁcantly  increased
by  the  administration  of mangafodipir  trisodium  (p  <  0.05).  Particularly,  contrast-enhanced  T1-weighted
LAVA  sequences  tended  to  out-perform  conventional  T2-weighted  MR  Cholangiography  in  the  delin-
eation  of anastomotic  and non-anastomotic  biliary  strictures  and  in the  diagnosis  of biliary  leak.
Conclusions:  Contrast-enhanced  T1-weighted  MR Cholangiography  may  improve  the  level  of diagnos-
tic  conﬁdence  provided  by  conventional  T2-weighted  MR  Cholangiography  in the  evaluation  of biliary
complications  after  orthotopic  liver  transplantation.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd. This  is an open  access  article  under  the  CC  BY-NC-ND. Introduction
Orthotopic liver transplantation (OLT) is actually considered the
est treatment option for end-stage liver disease, as well as for
cute hepatic failure [1]. Despite the continuous improvement in
urvival over the years [2], biliary complications are still common
nd represent important causes of mortality (between 2% and 7%),
orbidity, and graft dysfunction after OLT. Adverse events such as
iliary strictures, stones and leakages, can occur in a percentage
anging between 5.8% and 24.5% of adult liver transplant recipients
nd their prompt identiﬁcation and appropriate management is
ssential for the survival of graft and patient [3,4].
∗ Corresponding author.
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.0/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Several authors [5–11] have reported that MR  Cholangiogra-
phy (MRC) has good results in identifying biliary complications
following liver transplantation, suggesting that it may  be a reli-
able non-invasive diagnostic method for imaging the biliary tract
in these patients. Mangafodipir trisodium (Mn-DPDP, Teslascan®)
is a contrast agent that consists of an organic ligand, fodipir (DPDP)
and manganese (Mn) [12]. This hepato-biliary contrast medium is
administered intravenously, taken up by the liver, and transported
to bile, where it causes shortening of the T1 relaxation time as a
result of paramagnetic effects of manganese ion [13]. Since it is
excreted via the biliary tract in a percentage of about 20%, Mn-
DPDP-enhanced T1-weighted MR  cholangiograms may potentially
increase reliability of MR  examination or decrease the occurrence
of a non-diagnostic or equivocal interpretation.
Our study was aimed to assess whether contrast-enhanced
MR  Cholangiography may  provide additional information in the
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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valuation of biliary complications in orthotopic liver transplant
ecipients.
. Material and methods
.1. Patients
A series of eighty consecutive patients (57 males and 23 females;
ge range: 19–67 years; mean age: 53 years) prospectively under-
ent MR  examination between three and twenty-four months after
iver transplant.
Liver transplantations were all full grafts from deceased donors.
he indications for liver transplantation were represented by
epatocellular carcinoma (n = 23), HCV-related hepatic cirrhosis
n = 19), HBV-related hepatic cirrhosis (n = 3), mixed HBV/HDV-
elated hepatic cirrhosis (n = 7), alcoholic cirrhosis (n = 9), fulminant
epatic failure (n = 6), cryptogenic hepatic cirrhosis (n = 6), Budd-
hiari syndrome (n = 1), primary biliary cirrhosis (n = 1), primary
clerosing cholangitis (n = 1), Caroli’s disease (n = 1), cholangiocar-
inoma (n = 1), polycystic hepatic disease (n = 1), hepatic alveolar
chinococcosis (n = 1).
The MR  examinations were performed for altered liver function
ests (elevated ALT, AST, gamma-glutamyl transpeptidase, alkaline
hosphatase, bilirubin) associated or not to abnormalities at ultra-
ound (biliary dilation; biliary wall thickening; suspected lithiasis;
iver parenchymal abnormalities).
In our series biliary reconstruction was performed with
holedocho-choledochostomy in seventy-ﬁve patients (71 with
nd 4 without a T-tube stent) and with hepatico-jejunostomy in
ve subjects. A T-tube is usually placed through a choledochotomy
n the recipient common bile duct and left in place for about three
onths in order to monitor bile and stent the anastomosis with its
roximal limb; in our liver transplant center T-tube cholangiogra-
hy is performed if necessary during this period and in all cases,
efore the removal of T-tube. Direct cholangiographic techniques,
epresented by endoscopic retrograde cholangiography (ERC) or
ercutaneous trans-hepatic cholangiography (PTC), were utilized
n 46 patients within 7 days of the MR  examination, and were
onsidered the “gold standard” methods for biliary tree imaging.
n 14 subjects requiring surgery, surgical ﬁndings associated with
maging and interventional procedures were used to validate MRI
esults. In the remaining 20 recipients in which no biliary abnor-
ality was identiﬁed at MR  examination, clinical follow-up was
ntegrated with ultrasound and/or MR  imaging for a period of at
east twelve months (ultrasound every 3 months and MR  exam
very 6 months).
Institutional review board approval was obtained for this study
nd a written informed consent was signed by all the enrolled
atients after the nature of the procedure had been fully explained.
.2. MR  imaging and MR  Cholangiography
MR  examinations were performed with a 1.5 T scanner (Signa
Dx; GE Healthcare, Milwaukee, Wis) utilizing a twelve-channel
hased-array body coil.
In order to improve the visualization of the duodenum, 300 ml
f water was orally administered about 10 min  before MR  exam.
esides, immediately before starting MR  imaging, scopolamine
ethyl-bromide (Buscopan® 20 mg/ml, Boehringer Ingelheim) was
ntramuscularly administered in order to avoid peristaltic artefacts.
The imaging protocol began with axial, breath-hold, withnd without fat-suppression, spoiled gradient-echo (SPGR) T1-
eighted images (repetition time, 110–130 ms;  echo time,
inimum full, with effective 2.1–2.3 ms;  ﬂip angle, 80◦; section
hickness, 5 mm;  interslice gap, 0.5 mm;  matrix size, 256 × 192adiology Open 3 (2016) 108–116 109
pixels; signal averaged, 1; acquisition time, 28–32 s), axial,
respiratory-triggered, fat-suppressed, fast spin-echo (FSE) T2-
weighted sequence (repetition time automatically adapted to the
patient’s breathing pattern, 6000–18000 ms;  echo time, 95.5 ms;
echo train length, 16; section thickness, 5 mm;  interslice gap,
0.5 mm;  signals averaged, 3–4; acquisition time, 3–4 min) and/or
axial, breath-hold, single-shot fast spin-echo (SSFSE) T2-weighted
sequence (repetition time, minimum; echo time, 80 ms;  section
thickness, 5 mm;  interslice gap, 0.5 mm;  signal averaged, 0.5–0.6;
acquisition time, 18–24 s) in order to cover the liver and the biliary
tract.
MR Cholangiography was  performed utilizing a coronal
respiratory-triggered, fat-suppressed, two-dimensional, heavily
T2-weighted fast spin-echo sequence, the imaging parameters of
which were: repetition time (automatically adapted to the patient’s
breathing pattern), 4500–9000 ms;  echo time, 504 ms; echo train
length, 16–32; section thickness, 2–2.5 mm with no interslice gap;
ﬁeld of view, 35–45 cm;  matrix size, 224 × 192 pixels; 2–4 sig-
nals averaged. Anterior-posterior spatial pre-saturation was used
for all of the images. The receive bandwidth was 62.5 kHz, and
ﬂow compensation and extended dynamic range options were
also used. The images were acquired over a period of 2–4 min.
Coronal breath-hold, thick-slab, single-shot fast spin-echo (SSFSE)
T2-weighted sequences (effective echo time, 1102 ms;  thickness,
10 and 40–50 mm;  ﬁeld of view, 35–45 cm;  matrix size, 448 × 224
pixels; 0.5 signal acquired; acquisition time, 2–3 s for every image)
were also acquired. The pre-contrast study represented our image
set 1.
Our protocol then included a three-dimensional fat-suppressed
breath-hold gradient-echo T1-weighted LAVA (Liver Acquisition
with Volume Acceleration) sequence obtained 30 min  after the
end of the intravenous infusion of mangafodipir trisodium (Mn-
DPDP, Teslascan®; GE Healthcare) in the coronal and axial
planes. In all patients, Mn-DPDP was infused intravenously at a
dosage of 0.5 ml/kg, with a ﬂow-rate of 2–3 ml/min, over about
10–12 min. The parameters of this sequence were the following:
4.3–4.1/2.0–1.9, repetition time ms/echo time ms; 7.0, inver-
sion time, ms;  15◦, ﬂip angle; 2.0–2.4 mm slab thickness/−1.0 to
1.2 mm spacing; 380–450 mm,  ﬁeld of view; 224 × 192, matrix
size; 1, signals acquired and 15–18 s acquisition time. Post-contrast
T1-weighted sequences were also obtained in a delayed phase,
between 60 and 120 min  after contrast agent administration in 22
out of 80 patients. The post-contrast study represented our image
set 2.
2.3. Image analysis
Two  experienced abdominal radiologists reviewed in confer-
ence the MR images and applied Maximum Intensity Projection
(MIP), Volume Rendering (VolRend) and other multiplanar refor-
matting techniques to the data sets of coronal thin-slab fast
spin-echo T2-weighted sequence and coronal contrast-enhanced
T1-weighted LAVA sequence on an independent workstation con-
nected to the MR  scanner (Advantage Windows 4.4; GE Healthcare).
The observers were blinded to patient identiﬁcation and all clinical,
laboratory, and previous imaging ﬁndings.
The MR  exams were evaluated at the console in an ongoing man-
ner (after the study was  done) for the depiction of biliary anatomy
and for the presence of biliary system complications such as intra-
and extra-hepatic biliary ductal dilatation, strictures, stones, leak-
age and so on. MR  studies were considered to be diagnostic by
the two  reviewers when they well exhibited the biliary anatomy
including visualization of the surgical anastomosis. The maximum
caliber of the pre- and post-anastomotic common bile duct was  also
measured at the console; the intra- and extra-hepatic bile ducts
110 P. Boraschi et al. / European Journal of R
Table 1
Biliary complications in our series of 80 liver transplanted patients.
Findings No. of patients
Anastomotic stricture 15
Non-anastomotic stricture including typical ITBL 28
Sphincter of Oddi dysfunction (SOD) 10
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eBiliary stones, sludge, and casts 22
Biliary leakage 6
Patients with regular or normal biliary tree anatomy 21
ere considered to be dilated if their diameter exceeded 2 and
 mm,  respectively.
Subsequently, the diagnostic value of mangafodipir trisodium-
nhanced MR  Cholangiography to identify presence and site of
iliary complications was tested by separate analysis results of
mage set 1 alone and image set 1 and 2 together. The level of
iagnostic conﬁdence of different image sets was graded using a 3-
oint-scale: not very conﬁdent (1); moderately conﬁdent (2); very
onﬁdent (3).
Other two observers (a radiologist and a surgeon) analyzed in
onference the ERC and the PTC images using the clinical, labora-
ory, endoscopic and imaging data during their review.
.4. Statistical analysis
The distribution of qualitative variables was expressed as the
elative frequency of the various modalities under observation. The
istribution of quantitative variables was expressed as the mean,
inimum, maximum and number of observations.
MRI  ﬁndings were correlated with direct cholangiography,
urgery and/or clinical-radiological follow-up and deﬁned as true
ositives when they correctly identiﬁed biliary complications con-
rmed by the ﬁnal diagnosis reference standards; false positives
hen they were not conﬁrmed by direct cholangiography, surgery
nd/or clinical-radiological follow-up; false negatives when com-
lications detected by direct cholangiography, surgery and/or
linical-radiological follow-up were not observed by MR  exam-
nation; true negatives when the absence of complications was
onﬁrmed by direct cholangiography, surgery and/or clinical-
adiological follow-up.
Sensitivity, speciﬁcity, diagnostic accuracy, positive predictive
alue (PPV), and negative predictive value (NPV) of the reviewers
or the detection of all types of biliary complications were calcu-
ated in order to evaluate the diagnostic yield of MR  imaging. The
evel of diagnostic conﬁdence of image set 1 alone versus image set
 and 2 together (including Mn-DPDP-enhanced images) was  com-
ared using receiver operating characteristic (ROC) analysis. The
iagnostic accuracy was estimated by calculating the area under
he ROC curve.
A p value less than 0.05 was considered signiﬁcant.
. Results
MR  studies were judged diagnostic by the two reviewers in all
ighty patients.
Various biliary complications were identiﬁed in 59 out of the
0 liver recipients (74%) and are reported in Table 1. Twenty-one
ubjects showed regular or normal biliary tree anatomy, whereas
n the remaining ﬁfty-nine patients one or more of the follow-
ng complications were observed: anastomotic strictures (n = 15),
on-anastomotic strictures including typical “ischemic-type biliary
esions” (ITBL) (n = 28), sphincter of Oddi dysfunction (SOD) (n = 10),
iliary stones, sludge, and casts (n = 22) and biliary leakage (n = 6).
In our series non-anastomotic strictures including typical
schemic-type biliary lesions were the most frequent adverse
vents; they prevalently involved the hepatic conﬂuence and extra-adiology Open 3 (2016) 108–116
hepatic biliary system of the graft and were conﬁrmed by gold
standard methods in all 28 cases. Mn-DPDP allowed a better
depiction and a more precise delineation of the extension of the
restricted biliary segment, particularly at the level of hepatic bifur-
cation (Fig. 1). In a recipient a left hepatic duct stricture on MR
imaging was  not considered signiﬁcant on ERC and was  not endo-
scopically treated (1 false positive case).
On the other hand, in 14 out of 15 cases of anastomotic stric-
tures, the site of biliary obstruction was correctly assessed by the
reviewers and the dilated biliary system above the stenosis was
completely visualized on MR  images; there was a 100% correlation
between MR Cholangiography and direct cholangiography ﬁndings
or surgical reports (Fig. 2). In two of these patients no excretion
of the hepato-biliary contrast agent was observed after two hours
from administration and so contrast-enhanced T1-weighted MRC
was not obtained. Direct cholangiography did not conﬁrm an anas-
tomotic stricture diagnosed on MRC  images (1 false positive case);
in this patient the discrepancy in the calibre of the donor and recip-
ient common bile ducts (ratio 2:1) was  interpreted as a stricture at
the anastomotic site, but it was due to the anatomical conforma-
tion of pre- and post-anstomotic biliary tree. Another anastomotic
stricture graded as mild on ERC was  misdiagnosed as an artefact at
MR  Cholangiography (1 false negative).
The reviewers correctly identiﬁed all cases of biliary stones,
sludge, and casts (n = 22) in the extra-hepatic biliary tract on MR
images. Stones were typically recognized as low-signal-intensity
areas surrounded by high-signal-intensity bile in the posterior por-
tion of the ducts on axial images and were seen alone or associated
with both anastomotic and non-anastomotic strictures (Fig. 3).
Moreover, on the combined set of MR images (set 1 and set 2
together) the reviewers diagnosed all six cases of biliary leakage;
this was due to the fact that contrast-enhanced MRC was partic-
ularly helpful in identifying the site of the bile leak and directly
visualized contrast material extravasation into the ﬂuid collections
(Fig. 4).
At last, in all the patients with sphincter of Oddi dysfunction we
observed on MR  images a signiﬁcant dilatation of both recipient
and donor common bile duct in the presence of narrowing of the
terminal portion of recipient’s common bile duct. In these cases,
contrast-enhanced MR  imaging also allowed to obtain functional
information on the degree of biliary obstruction and increased the
diagnostic conﬁdence of un-enhanced MR  images.
Overall, on the basis of observers’ readings of combined image
set 1 and image set 2 (pre-contrast study including T2-weighted
MRC  and contrast-enhanced MR Cholangiography), post-OLT eval-
uation of the biliary system with MR  imaging resulted in 99 correct
diagnoses (accuracy, 97%) and 3 (3%) incorrect diagnoses. Sen-
sitivity, speciﬁcity, positive predictive value (PPV), and negative
predictive value (NPV) of the reviewers’ readings for the diagnosis
of all types of biliary adverse events in liver recipients were 99%,
90%, 98% and 95%, respectively.
The level of conﬁdence in the assessment of biliary adverse
events was  signiﬁcantly increased by the administration of man-
gafodipir trisodium as demonstrated by ROC analysis of two
different image sets (Fig. 5). The difference between areas under
the ROC curve of two different images sets was 0.313 +/−  0.093,
showing signiﬁcance level (p = 0.001).
4. Discussion
Whenever a biliary complication is suspected in a liver trans-
plant recipient, diagnostic work-up usually begins with laboratory
tests and an abdominal Doppler ultrasound (US) that allows the
simultaneous evaluation of liver parenchyma, biliary tree and hep-
atic vasculature. The positive predictive value of abdominal US
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Fig. 1. (A–D) 52-year-old man  with progressive jaundice. Conventional coronal thick-slab single-shot MRC  (A) and MIP  reconstructions from 3D-T2-weighted images (B) do
not  visualize the conﬂuence of the hepatic ducts and the common hepatic duct of the graft; slight dilation of the intrahepatic biliary system is well evident. MIP  reconstructions
obtained from MnDPDP-enhanced 3D T1-weighted MRC  (C) better delineate narrowed and irregular donor’s extrahepatic biliary tract, in particular at the level of the right
(white  arrow) and the common (red arrow) hepatic ducts. Findings of typical ITBL were conﬁrmed at ERC (D) and treated with a biliary stent. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web  version of this article.).
112 P. Boraschi et al. / European Journal of Radiology Open 3 (2016) 108–116
Fig. 2. (A–D) 44-year-old man  with biochemical parameters of cholestasis. Conventional coronal thick-slab single-shot MRC  (A) and MIP  reconstructions from 3D T2-weighted
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emages  (B) show dilation of donor’s biliary tree; long discontinuity is suggested at a
RC  (C) well exhibit the length and degree of anastomotic stricture (white arrow).
nastomotic site; stricture was endoscopically treated and a biliary stent was  place
s very high, especially in the presence of dilated bile ducts. In
he absence of dilated bile ducts, the sensitivity of the ultra-
ound for detecting biliary obstruction ranges from 38% to 68%
14]. Although ultrasound is a non-invasive method of identifying
dverse events in liver recipients, a normal US exam cannot exclude
he presence of biliary strictures, widespread ductal abnormalities
r bile leak [15,16]. Multi-detector computed tomography is usu-
lly performed in the period after transplant when US ﬁndings are
quivocal or there is a strong clinical suspicion for an abnormal-
ty. This imaging technique is a reliable and non-invasive mean
f visualizing hepatic artery, portal vein, hepatic veins, and infe-
ior vena cava and evaluating non-vascular graft complications and
xtra-hepatic organs. As concerns as biliary adverse events, com-otic site. MIP  reconstructions obtained from Mn-DPDP-enhanced 3D T1-weighted
D), obtained in the same patient, conﬁrms the presence of a biliary stricture at the
puted tomography can be utilized to screen for biliary leakage or
obstruction, but its role has not yet deﬁnitely clariﬁed [17,18].
A more efﬁcient evaluation of biliary adverse events can be
obtained utilizing T-tube cholangiography or invasive techniques,
such as endoscopic retrograde cholangiopancreatography (ERCP)
or percutaneous trans-hepatic cholangiography (PTC). In recipients
with a suspicion of biliary complications in the early period fol-
lowing liver transplant during which the T-tube is still in place,
T-tube cholangiography is the examination of choice. On the other
hand, when the T-tube is removed three months after OLT or in the
case it is not used at all, direct visualization of the biliary tract is
only possible when using invasive techniques, which are associated
with various complications in 3.4% of PTC and 1–7% of ERCP. Nev-
P. Boraschi et al. / European Journal of Radiology Open 3 (2016) 108–116 113
Fig. 3. (A–F) 62-year-old patient with abnormal liver function tests. Axial T2-weighted image (A) and conventional coronal thick-slab single-shot MRC (B) well exhibit
d mon b
s ow). 3
r ost-ER
e
b
o
l
i
a
c
p
ﬁ
a
r
i
M
iilation  of extrahepatic biliary tree and a signal void in the distal portion of the com
tone  as a low signal intensity ﬁlling defect in contrast-ﬁlled bile ducts (white arr
ecipient’s common bile duct. Stone was endoscopically removed as conﬁrmed at p
rtheless, in patients with bilio-digestive anastomoses ERCP may
e unsuccessful or extremely difﬁcult since endoscopic approach
f the biliary tract is generally precluded because technically chal-
enging [19,20].
As a non-invasive alternative to direct cholangiography, MRC
s actually very important for assessing biliary tree abnormalities
fter surgery [5]. In a recent meta-analysis Jorgensen et al. [21] con-
luded that MRCP may  have an excellent diagnostic accuracy for
ost-OLT biliary obstruction, with a global sensitivity and speci-
city of 96% and 94%, respectively; on the basis of these results an
ppropriate use of MRCP could potentially prevent the unnecessary
isks of invasive procedures in this clinical setting. Furthermore,
n a still more recent meta-analysis Xu et al. [22] conﬁrmed that
RCP is a highly accurate diagnostic technique for diagnosing bil-
ary complications and strictures in patients who  have undergoneile duct. Axial (C) and coronal (D) Mn-DPDP-enhanced T1-weighted images depict
D MIP  reconstruction (E) also demonstrates narrowing of the terminal portion of
CP direct cholangiography (F).
OLT. However, the main disadvantages of conventional MRCP are
that it lacks functional information and so, differentiation between
obstructive and non-obstructive dilatation of the bile ducts is often
extremely difﬁcult [23,24]. Depiction of anatomy and lesion detec-
tion can be inadequate in a non-dilated biliary system; besides, free
ﬂuid and leak in the vicinity obscures the biliary anatomy due to
overlapping [25,26]. Hence, there is often a need for a non-invasive
imaging modality, which can provide reliable anatomic as well as
functional information.
T1-weighted contrast-enhanced MR  Cholangiography with
intravenous administration of hepato-biliary contrast agents such
as Mn-DPDP, Gd-BOPTA and Gd-EOB-DTPA [27] is a relatively
recent MR technique that may  provide both anatomic and func-
tional information on the biliary system. These agents are taken up
by functioning hepatocytes and excreted into the biliary system
114 P. Boraschi et al. / European Journal of Radiology Open 3 (2016) 108–116
Fig. 4. (A–C) 58-year-old woman  with abdominal pain. Conventional coronal thick-slab single-shot MRC  (A) and MIP  reconstructions from 3D-T2-weighted images (B) show
an  huge sub-hepatic ﬂuid collection partially obscuring the biliary tract. MIP reconstructions obtained from Mn-DPDP-enhanced 3D T1-weighted MRC  (C) demonstrate the
presence of a leakage at the anastomotic with contrast-enhanced bile ﬁlling of the sub-hepatic collection (white arrows).
Fig. 5. Graph shows ROC analysis of two image sets (conventional T2-weighted MRC  image set versus all images set including Mn-DPDP-enhanced MRC) concerning the
level  of conﬁdence in the diagnosis of biliary adverse events (p = 0.001).
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3–5% for Gd-BOPTA, 20% for Mn-DPDP, and 50% for Gd-EOB-
TPA). Hepatic excretion of hepato-biliary contrast agents results
n enhancement of biliary structures and it is likely to have a
reat impact on better visualization of biliary system [28]. In a
reliminary experience on 13 patients with hepaticojejunostomy,
ottat et al. [24] concluded that contrast-enhanced T1-weighted
RC with intravenous administration of Mn-DPDP provides use-
ul anatomic and functional information in patients suspected
f having biliary obstruction on conventional T2-weighted MR
holangiography. Various authors have recently underlined how
epatocyte-speciﬁc contrast-enhanced MR  Cholangiography could
ffer additional information to referring clinicians and have
eported the possible clinical applications in the evaluation of bil-
ary pathology [29–32].
However, to the best of our knowledge, no study has been previ-
usly published on the possible added value of contrast-enhanced
R Cholangiography using Mn-DPDP in the evaluation of biliary
dverse events following liver transplantation.
On the basis of our experience, MR  studies including Mn-
PDP-enhanced sequences allowed complete visualization of the
xtra-hepatic biliary tree and provided functional information in
ur series of patients. In fact, times of contrast agent excretion
eem to be in correlation with different degrees of biliary obstruc-
ion and related to the severity of the strictures. In the two  patients
ith anastomotic strictures in which no excretion of Mn-DPDP was
bserved after two hours from contrast agent administration, the
everity of the biliary strictures was conﬁrmed on surgery.
Using conventional T2-weighted MRC  and contrast-enhanced
R  Cholangiography we correctly identiﬁed 42 out of 43 biliary
nstomotic and non-anastomotic strictures with a false negative
ase and two false positive cases. The extension and degree of anas-
omotic and non-anastomotic strictures were better delineated
hen using Mn-DPDP-enhanced MR  Cholangiography respect
o conventional T2-weighted MRC. In our hospital, transplant
urgeons actually select the more appropriate treatment (interven-
ional or surgical) of the biliary strictures on the basis of the extent
nd grading of biliary involvement on MRC  images.
Nevertheless, we correctly identiﬁed all six cases of biliary leak-
ge due to the use of contrast-enhanced MRC  with intravenous
dministration of Mn-DPDP. Although cross-sectional imaging can
uspect the diagnosis of a biliary leakage in an appropriate clinical
cenario, non-speciﬁc ﬁndings (e.g., ﬂuid collection) are generally
rovided [29]. Invasive techniques such as PTC or, less frequently,
RCP are often utilized to conﬁrm the diagnosis by demonstrating
n active contrast extravasation from the biliary system. However,
n our patients we were able to directly visualize contrast material
xtravasation into ﬂuid collections on contrast-enhanced MRC  and
o we could also identify the anatomic site of the leak.
Although the ability of MR  imaging to consistently identify cal-
uli of a few millimeters in size has not yet fully demonstrated,
umerous published studies have shown an excellent diagnostic
ccuracy of MR  Cholangiography in the detection of common bile
uct stones [33]. In our series of patients Mn-DPDP-enhanced MRC
elped to exclude pathologic conditions and provided an increased
iagnostic conﬁdence in the differential diagnosis between endolu-
inal ﬁlling defects (such as biliary stones, sludge, and casts) and
neumobilia or ﬂow artefacts. Furthermore, T1-weighted images
mproved the diagnostic conﬁdence of conventional T2-weighted
RC  for the detection of biliary cast syndrome in recipients with
TBL since biliary cast is hyperintense on T1-weighted images.
At least, in our series Mn-DPDP-enhanced MRC  allowed an
ncreased diagnostic conﬁdence for the diagnosis of sphincter of
ddi dysfunction since it provided functional information on bil-
ary ﬂow dynamics. Delayed passage of bile through the ampulla of
ater might be caused by observing delayed passage or no passage
f contrast medium in the ampulla of Vater on MR  images usu-adiology Open 3 (2016) 108–116 115
ally obtained more than 1–2 h after Mn-DPDP injection. In addition,
mangafodipir trisodium-enhanced MR  Cholangiography may  help
to exclude the possibility of SOD by demonstrating normal passage
of contrast material in the biliary tract on MR  images obtained after
a 30 min  delay in patients clinically suspected to have sphincter of
Oddi dysfunction.
On the basis of our data, the proposed combined approach
using conventional T2-weighted MRC  and mangafodipir trisodium-
enhanced MR  Cholangiography may  predict biliary adverse events
in at least 98%, and exclude them in 95% of cases. It can accurately
demonstrate the site and extent of biliary strictures, which is very
useful when planning possible interventional treatments. Besides,
it can allow a more reliable diagnosis of very small biliary stones
and particularly of biliary leakage, that is extremely difﬁcult when
only using conventional T2-weighted images; at last, it can provide
functional information that are very promising in the grading the
level and severity of biliary obstruction.
The drawbacks of contrast-enhanced MRC  using mangafodipir
trisodium are mainly represented by its additional costs, by the
fact that it is a time-consuming technique and by limitations in
delineating the biliary tract in patients with hepato-biliary dys-
function. Another potential limitation may  be represented by the
fact that mangafodipir trisodium (Teslascan) is currently no longer
available commercially; however, in our opinion, the same results
of our study can be theoretically obtained using other alternative
contrast agents commercially available such as Gd-BOPTA and Gd-
EOB-DTPA. Obviously, further prospective studies utilizing other
hepato-biliary contrast media are needed to conﬁrm the usefulness
of this combined approach in the assessment of biliary complica-
tions after liver transplantation.
5. Conclusions
In summary, contrast-enhanced MR Cholangiography using
mangafodipir trisodium may  improve the level of diagnostic conﬁ-
dence provided by conventional T2-weighted MR Cholangiography
for detecting biliary adverse events following orthotopic liver
transplantation since it can provide both anatomical and functional
information. For this reason, we actually recommend to utilize
this diagnostic approach before planning every kind of therapeutic
approach.
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